NORTHWEST BIOTHERAPEUTICS INC (NWBO) Operating cash flow 2016–2025
NORTHWEST BIOTHERAPEUTICS INC (NWBO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$44.8MFY2025 · since FY2016: -$55.7M → -$44.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$44.8M | +21.5% |
| FY2024 | -$57.0M | -6.3% |
| FY2023 | -$53.6M | -1.6% |
| FY2022 | -$52.8M | -37.8% |
| FY2021 | -$38.3M | -19.3% |
| FY2020 | -$32.1M | -0.7% |
| FY2019 | -$31.9M | +7.9% |
| FY2018 | -$34.6M | +5.2% |
| FY2017 | -$36.5M | +34.4% |
| FY2016 | -$55.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NWBO financial trends
NWBO RevenueNWBO Net incomeNWBO Net marginNWBO Gross profitNWBO Gross marginNWBO Operating incomeNWBO Operating marginNWBO Free cash flowNWBO Capital expendituresNWBO Return on equityNWBO Stock buybacksNWBO Dividends paidNWBO Total assetsNWBO Total liabilitiesNWBO Shareholders’ equityNWBO overview →